AIMEDBIO
IR
ENG
KOR
ABOUT US
Overview
Leadership
Corporate Governance
R&D
AimedBio’s Drug Development
P-ADC™
Pipeline
IR
Disclosure
Stock
Financial Information
PR
Notice
Press Release
Data Room
CAREERS
Our Culture
Recruitment Process
Job Opportunities
Disclosure
54 posts
NO.
Title
Date
Author
14
Report on significant holdings of stocks, etc. (Short form)
2025-12-08
에스엠비투자파트너스
13
Report on significant holdings of stocks, etc. (Short form)
2025-12-05
에스브이아이씨54호 신기술사업투자조합
12
Post-issuance report
2025-11-26
에임드바이오
11
[Corrected description]Prospectus
2025-11-20
에임드바이오
10
[Conditions for issuance finalized]Registration Statement (Equity securities)
2025-11-20
에임드바이오
9
Prospectus
2025-11-18
에임드바이오
8
[Corrected description]Registration Statement (Equity securities)
2025-11-17
에임드바이오
7
[Corrected description]Registration Statement (Equity securities)
2025-11-10
에임드바이오
6
[Corrected description]Registration Statement (Equity securities)
2025-10-27
에임드바이오
5
[Added attachment]Registration Statement (Equity securities)
2025-09-29
에임드바이오
Report on significant holdings of stocks, etc. (Short form)
에스엠비투자파트너스
2025-12-08
Report on significant holdings of stocks, etc. (Short form)
에스브이아이씨54호 신기술사업투자조합
2025-12-05
Post-issuance report
에임드바이오
2025-11-26
[Corrected description]Prospectus
에임드바이오
2025-11-20
[Conditions for issuance finalized]Registration Statement (Equity securities)
에임드바이오
2025-11-20
Prospectus
에임드바이오
2025-11-18
[Corrected description]Registration Statement (Equity securities)
에임드바이오
2025-11-17
[Corrected description]Registration Statement (Equity securities)
에임드바이오
2025-11-10
[Corrected description]Registration Statement (Equity securities)
에임드바이오
2025-10-27
[Added attachment]Registration Statement (Equity securities)
에임드바이오
2025-09-29
1
2
3
4
5
